Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 9/20 | 0.50 |
| ▸ | BACE2 | Q9Y5Z0 | 9/20 | 0.50 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.48 |
| ▸ | APP | P05067 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1974862 | 1.00 | BACE1 (0.50) | BACE1BACE2TAAR1APP | |
| SCHEMBL1977346 | 0.85 | BACE1 (0.56) | BACE1BACE2 | |
| SCHEMBL1977348 | 0.85 | BACE1 (0.56) | BACE1BACE2 | |
| SCHEMBL16900332 | 0.84 | BACE1 (0.44) | BACE1BACE2TAAR1 | |
| SCHEMBL16900333 | 0.84 | BACE1 (0.45) | BACE1BACE2 | |
| Hydrochloric Acid SCHEMBL13268453 | 0.84 | BACE1 (0.55) | BACE1BACE2 | |
| SCHEMBL1974303 | 0.83 | BACE1 (0.48) | BACE1BACE2TAAR1APP | |
| SCHEMBL1974300 | 0.83 | BACE1 (0.48) | BACE1BACE2TAAR1APP | |
| SCHEMBL13268448 | 0.83 | BACE1 (0.52) | BACE1BACE2APP | |
| Formic Acid SCHEMBL14732153 | 0.79 | BACE1 (0.56) | BACE1BACE2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8389513-B2 | 2-amino-5,5-difluoro-5,6-dihydro-4H-[1,3]oxazin-4-yl)-phenyl]-amides | HOFFMANN-LA ROCHE INC. (US) | 2013-03-05 | — | — | US | disclosed |
| US-20110144097-A1 | 2-AMINO-5,5-DIFLUORO-5,6-DIHYDRO-4H-[1,3]OXAZIN-4-YL)-PHENYL]-AMIDES | F. HOFFMANN-LA ROCHE AG (CH) | 2011-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110144097-A1 | 2-AMINO-5,5-DIFLUORO-5,6-DIHYDRO-4H-[1,3]OXAZIN-4-YL)-PHENYL]-AMIDES | BACE2, BACE1, APP | BACE1 2/4885BACE2 1/4885TAAR1 3462/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.